CVKD Cadrenal Therapeutics, Inc.

NASDAQ

$1.15

Cadrenal Therapeutics, Inc. (CVKD) Earnings News

Earnings press releases, previews and reviews for Cadrenal Therapeutics, Inc. (CVKD), newest first.

Thursday August 13, 2026 4:15 PM ET

Cadrenal Therapeutics Reports Second Quarter 2026 Financial Results; Provides a Corporate Update on the Cardiac Acute Critical Care Franchise and the Strategic Partnering Process

Thursday May 7, 2026 8:30 AM ET

Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA

Tuesday March 31, 2026 8:45 AM ET

Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for HIT Following End-of-Phase 2 FDA Meeting